[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
Main Menu
Home::
Journal Information::
Articles Archive::
Guide for Authors::
For Reviewers::
Ethical Statements::
Registration::
Site Facilities::
Contact us::
::
Indexed by
    
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Copyright Policies

 

AWT IMAGE

 

..
Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

..
:: Volume 4 - The Autumn Supplement of Shefaye Khatam 2 - ::
Shefaye Khatam 2017, 4 - The Autumn Supplement of Shefaye Khatam 2 -: 34-34 Back to browse issues page
P12: Cell Therapies for Neurological Injury
Sara Abdolahi * , Sedigheh Ghasemi , Robabeh Jafari , Zeinab Najmi
a. Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran b. Department of Pathobiology, School of Veterinary Medicine, Shiraz University, Shiraz, Iran , abdolahisara65@gmail.com
Abstract:   (3766 Views)

A neurological disorder is any disorder of the nervous system is usually due to cell loss. The ultimate goal of CNS therapy is to replace lost cells and tissue. There is no neuroprotective, pharmacological and effective treatment available that restores the injury-induced loss of function. Recent studies suggest that identification of adult neural stem/progenitor cells indwelling in the neurogenic regions in the adult mammalian brain and spinal cord may play regenerative and reparative roles in response to CNS injuries. Therefore, cell transplantation is a potential strategy to repair and regenerate the injured brain and spinal cord. Different types of stem cells vary in their ability to help restore function, and an ideal treatment protocol remains unclear pending further clinical research. Stem cells derived from adult tissues such as mesenchymal progenitor cells, fetal progenitors, and post-mitotic cells have a limited potential to differentiate into specific cell types. As Brain and spinal cord injury are associated with enormous loss of multiple cell types due to primary mechanical tissue disruption. The choice of stem cell population used in replacement therapies after Brain and spinal cord injury might therefore be critical.

Keywords: Neurological injury, Cell therapies, Neural stem/progenitor cells
Full-Text [PDF 183 kb]   (942 Downloads)    
Type of Study: Review --- Open Access, CC-BY-NC | Subject: Basic research in Neuroscience


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Abdolahi S, Ghasemi S, Jafari R, Najmi Z. P12: Cell Therapies for Neurological Injury. Shefaye Khatam 2017; 4 (S2) :34-34
URL: http://shefayekhatam.ir/article-1-1134-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 4 - The Autumn Supplement of Shefaye Khatam 2 - Back to browse issues page
مجله علوم اعصاب شفای خاتم The Neuroscience Journal of Shefaye Khatam
Persian site map - English site map - Created in 0.07 seconds with 47 queries by YEKTAWEB 4710